AI Analysis AI Analysis of OCGN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add OCGN to Watchlist?
Some Reasons Why To Add OCGN:
  • High gross margin of 100.0%
  • Highly efficient cash conversion (100% FCF/OCF ratio)
  • +57.8% price growth over the last year
PDF

Green day on Thursday for Ocugen
(Updated on Jul 02, 2026)

Buy or Hold candidate since Jun 23, 2026 Gain 9.42%

The Ocugen stock price gained 2.03% on the last trading day (Thursday, 2nd Jul 2026), rising from $1.48 to $1.51. During the last trading day the stock fluctuated 7.02% from a day low at $1.50 to a day high of $1.60. The price has risen in 7 of the last 10 days and is up by 22.76% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 7 million shares were bought and sold for approximately $10.37 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -26.37% during the next 3 months and, with a 90% probability hold a price between $0.791 and $1.21 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

OCGN Signals & Forecast

The Ocugen stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.49 and $1.35. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -9.58%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Ocugen stock

Ocugen finds support from accumulated volume at $1.50 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.105 between high and low, or 7.02%. For the last week, the stock has had daily average volatility of 9.18%.

Our recommended stop-loss: $1.42 (-5.64%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (OCGN) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Ocugen Inc to open at $1.54, and during the day (based on 14 day Average True Range), to move between $1.46 and $1.56, which gives a possible trading interval of +/-$0.101 (+/-6.94%) up or down from last closing price. If Ocugen Inc takes out the full calculated possible swing range there will be an estimated 6.94% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.50 (0.66%) than the resistance at $1.67 (10.60%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Ocugen Inc stock A Buy?

Ocugen holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.104 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $1.54 ( 1.66%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

OCGN Performance

Trading levels for OCGN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.64 8.61%
R2 1.60 5.95%
R1 1.58 4.31%
Price 1.51
S1 1.49 -1.00%
S2 1.47 -2.64%
S3 1.43 -5.30%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.85 22.52%
R2 1.68 11.26%
R1 1.67 10.60%
Price 1.51
S1 1.50 -0.662%
S2 1.49 -1.32%
S3 1.24 -17.88%

FAQ

What is the symbol for Ocugen Stock and on which exchange is it traded?
The symbol for Ocugen is OCGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ocugen Stock?
Ocugen holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Ocugen Stock?
Ocugen Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ocugen Stock.

What's the current price of Ocugen Stock?
As of the end of day on the Jul 02, 2026, the price of an Ocugen (OCGN) share was $1.51.

What is the 52-week high and low for Ocugen Stock?
The 52-week high for Ocugen Stock is $2.73 and the 52-week low is $0.91.

What is the market capitalization of Ocugen Stock?
As of the Jul 02, 2026, the market capitalization of Ocugen is 511.168M.

When is the next earnings date for Ocugen?
The upcoming earnings date for Ocugen is Jul 30, 2026.
Click to get the best stock tips daily for free!
ABOUT OCUGEN INC
Ocugen
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related ...
GOLDEN STAR
Ticker Change Signal Date
B
BXDC
$21.71
1.11% Jun 29
SRPT
$17.02
13.28% Jun 29
OSIS
$218.29
1.59% Jun 26
NMRK
$15.02
4.66% Jun 24
JLL
$299.78
9.23% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE